Balyasny Asset Management
NUVB icon

Balyasny Asset Management’s Nuvation Bio NUVB Stock Holding History

Balyasny Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Buy
+62,521
New +$348K ﹤0.01% 2604
2025
Q4 		– Sell
-62,472
Closed -$231K – 3413
2025
Q3 		$231K Sell
62,472
-69,824
-53% -$190K ﹤0.01% 2677
2025
Q2 		$258K Buy
+132,296
New +$276K ﹤0.01% 2522
2024
Q4 		– Sell
-95,725
Closed -$219K – 3110
2024
Q3 		$219K Buy
+95,725
New +$292K ﹤0.01% 2536
2023
Q1 		– Sell
-44,098
Closed -$84.7K – 2998
2022
Q4 		$84.7K Buy
+44,098
New +$89.2K ﹤0.01% 2270
2021
Q2 		– Sell
-21,642
Closed -$226K – 2232
2021
Q1 		$226K Buy
+21,642
New +$242K ﹤0.01% 1561

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Balyasny Asset Management's NUVB Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Nuvation Bio (NUVB) in Q1 2026: 62,521 shares worth $268K. The stake represents ﹤0.01% of the portfolio and ranks #2604 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in NUVB as recently as Q3 2025.

Balyasny Asset Management first reported a position in NUVB in Q1 2021 and has held it in 6 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Balyasny Asset Management held 62,521 shares of Nuvation Bio worth $268K as of Q1 2026.
  • Nuvation Bio was a new Balyasny Asset Management position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2604 holding.
  • Balyasny Asset Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 6 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.